Kusajili – Clinical trials directory

Result of your search per sponsor: SangYoon Kim, MD

Woman and Man Max 99 years
SangYoon Kim, MD Update Il y a 4 ans

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia The purpose of this study is to evaluate the efficacy and safety of two fixed dose (1200mg/day, 1600mg/day) of INM-176 (a drug of treating dementia) comparing with donepezil for treatment ...

Country Korea, Republic of
organs None
Specialty None

Closed trial

More information